ストックスクリーナーアプリを入手
1.63
1.24%
0.02
アフターアワーズ：
1.65
0.02
+1.23%
前日終値:
$1.61
開ける：
$1.6
24時間の取引高:
2.63M
Relative Volume:
1.04
時価総額：
$171.63M
収益：
-
当期純損益:
$-37.34M
株価収益率:
-1.1985
EPS:
-1.36
ネットキャッシュフロー:
$-36.91M
1週間 パフォーマンス:
-11.89%
1か月 パフォーマンス:
-4.12%
6か月 パフォーマンス:
+34.71%
1年 パフォーマンス:
+33.61%
1日の値動き範囲:
$1.60
$1.66
1週間の範囲:
$1.60
$1.8885
52週間の値動き範囲:
$0.772
$2.2691
Sellas Life Sciences Group Inc Stock (SLS) Company Profile
名前
Sellas Life Sciences Group Inc
セクター
電話
(646) 200-5278
住所
7 TIMES SQUARE, NEW YORK, NY
SLS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SLS
Sellas Life Sciences Group Inc
|
1.63 | 169.53M | 0 | -37.34M | -36.91M | -1.36 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Sellas Life Sciences Group Inc Stock (SLS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-07-21 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-11-01 | 開始されました | Oppenheimer | Outperform |
| 2018-04-02 | 開始されました | H.C. Wainwright | Buy |
| 2018-03-19 | アップグレード | Maxim Group | Hold → Buy |
Sellas Life Sciences Group Inc (SLS) 最新ニュース
Stock Recap: Is SELLAS Life Sciences Group Inc trading at a discountDollar Strength & Growth-Oriented Investment Plans - khodrobank.com
Analysis Recap: Can SELLAS Life Sciences Group Inc stock double in the next yearFed Meeting & Short-Term Swing Trade Alerts - khodrobank.com
Retail Trends: Does SELLAS Life Sciences Group Inc align with a passive investing strategyTrend Reversal & Verified Momentum Stock Watchlist - khodrobank.com
Gainers Report: Is Goldman Sachs BDC Inc.’s growth already priced inShare Buyback & Low Risk Growth Stock Ideas - خودرو بانک
SELLAS Life Sciences Group (NASDAQ:SLS) Shares Down 9.2%Should You Sell? - MarketBeat
Analyst Upgrade: Can SELLAS Life Sciences Group Inc beat the S P 500Sell Signal & Reliable Trade Execution Plans - خودرو بانک
Growth Value: Is SELLAS Life Sciences Group Inc currently under institutional pressureWeekly Stock Report & Daily Volume Surge Signals - khodrobank.com
CEO Change: Does SELLAS Life Sciences Group Inc. stock benefit from AI growthJuly 2025 Catalysts & Trade Opportunity Analysis Reports - khodrobank.com
VIX Spike: Is Enviri Corporation stock a smart retirement pickInflation Watch & Weekly High Return Forecasts - خودرو بانک
Quarterly Earnings: What makes SELLAS Life Sciences Group Inc stock attractive todayJuly 2025 Setups & AI Powered Buy and Sell Recommendations - خودرو بانک
Smart Money: Is Fidelity National Information Services Inc exposed to currency risks2025 Dividend Review & Low Risk Investment Opportunities - خودرو بانک
Technical Analysis: Should I buy SELLAS Life Sciences Group Inc stock now2025 Analyst Calls & Daily Entry Point Trade Alerts - خودرو بانک
Movement Recap: What’s the analyst consensus on SBSWJuly 2025 Review & Daily Entry Point Alerts - khodrobank.com
Stop Loss: Is SELLAS Life Sciences Group Inc. stock heavily shortedJuly 2025 Breakouts & Daily Risk Controlled Trade Plans - khodrobank.com
Historical volatility pattern of SELLAS Life Sciences Group Inc. visualizedSell Signal & Capital Efficiency Focused Ideas - newser.com
Published on: 2025-09-14 09:49:04 - newser.com
Published on: 2025-09-14 09:04:21 - newser.com
SELLAS Life Sciences’ Recent Warrant Inducement Agreement - MSN
Sellas Life Sciences Stock In Spotlight After Institutional Investor Exercises Existing Warrants - Stocktwits
Sellas Life Sciences to Receive $23.6 Million From Exercise of Warrants - MarketScreener
Sellas Life Sciences secures $23.6 million in gross proceeds through institutional warrant exercise - MarketScreener
SELLAS Life Sciences Group Announces Exercise of Existing Warrants Held by a Current Institutional Investor for $23.6 Million in Gross Proceeds - The Manila Times
SELLAS Life Sciences Group Announces Exercise of Existing - GlobeNewswire
$23.6M Capital Raise: SELLAS Life Sciences Completes Major Warrant Exercise with New Warrants Issued - Stock Titan
Aug Catalysts: Is SELLAS Life Sciences Group Inc. stock heavily shortedJuly 2025 Summary & Verified Technical Trade Signals - Lancaster City Council
Published on: 2025-09-08 15:44:09 - beatles.ru
Should you hold or exit SELLAS Life Sciences Group Inc. nowMarket Risk Summary & Safe Capital Growth Trade Ideas - Newser
SELLAS Life Sciences Group Inc. Reversal Rally May Surprise BearsMarket Growth Report & Free Risk Controlled Daily Trade Plans - beatles.ru
Is SELLAS Life Sciences Group Inc. stock heavily shortedQuarterly Trade Summary & AI Driven Stock Reports - خودرو بانک
Is SELLAS Life Sciences Group Inc. a strong growth stockJuly 2025 Action & Accurate Buy Signal Alerts - خودرو بانک
Real time breakdown of SELLAS Life Sciences Group Inc. stock performanceWeekly Investment Recap & Fast Gain Stock Trading Tips - Newser
What’s next for SELLAS Life Sciences Group Inc. stock price2025 Earnings Surprises & Low Risk Entry Point Guides - Newser
Building trade automation scripts for SELLAS Life Sciences Group Inc.2025 Valuation Update & Weekly High Return Opportunities - Newser
Trend analysis for SELLAS Life Sciences Group Inc. this week2025 Sector Review & Technical Confirmation Trade Alerts - Newser
Sentiment analysis tools applied to SELLAS Life Sciences Group Inc.July 2025 Review & Fast Gaining Stock Reports - Newser
Does SELLAS Life Sciences Group Inc. stock benefit from AI growthJuly 2025 Update & Stepwise Trade Signal Guides - خودرو بانک
Is SELLAS Life Sciences Group Inc. still worth holding after the dip2025 Winners & Losers & Daily Profit Focused Screening - Newser
Sector ETF performance correlation with SELLAS Life Sciences Group Inc.Quarterly Trade Summary & Community Consensus Trade Alerts - Newser
What earnings revisions data tells us about SELLAS Life Sciences Group Inc.Sell Signal & Capital Efficiency Focused Ideas - Newser
Price action breakdown for SELLAS Life Sciences Group Inc.July 2025 Patterns & Daily Profit Maximizing Tips - Newser
SELLAS Life Sciences Group Inc. stock daily chart insightsJuly 2025 Market Mood & Risk Managed Investment Strategies - Newser
Is SELLAS Life Sciences Group Inc. stock good for income investorsWeekly Volume Report & AI Driven Stock Reports - خودرو بانک
Has SELLAS Life Sciences Group Inc. formed a bullish divergenceWeekly Trade Report & Precise Swing Trade Entry Alerts - Newser
Real time alert setup for SELLAS Life Sciences Group Inc. performanceQuarterly Trade Report & Proven Capital Preservation Methods - Newser
Should value investors consider SELLAS Life Sciences Group Inc.2025 Bull vs Bear & Detailed Earnings Play Strategies - خودرو بانک
What does recent volatility data suggest for SELLAS Life Sciences Group Inc.2025 Pullback Review & Low Risk Growth Stock Ideas - Newser
What dividend growth rate does SELLAS Life Sciences Group Inc. offerJuly 2025 Review & Verified Trade Idea Suggestions - خودرو بانک
What MACD signals say about SELLAS Life Sciences Group Inc.July 2025 Decliners & Consistent Growth Equity Picks - Newser
How much upside does SELLAS Life Sciences Group Inc. haveMarket Activity Report & Verified Entry Point Detection - خودرو بانک
Intraday Charts Show Spike in SELLAS Life Sciences Group Inc. Activity2025 Fundamental Recap & Consistent Income Trade Recommendations - beatles.ru
Sellas Life Sciences Group Inc (SLS) 財務データ
収益
当期純利益
現金流量
EPS
1.43%
0.09%
大文字化:
|
ボリューム (24 時間):